Carolyn M. Hendrickson

Intensive Care Medicine

1001 Potrero Ave Rm 5K1
San Francisco, CA 94110

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

Journal: Chest

Published: March 25, 2026

Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics.

Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics.

Journal: American journal of respiratory and critical care medicine

Published: January 23, 2026

Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With Sepsis.

Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With Sepsis.

Journal: Critical care medicine

Published: October 28, 2025

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes.

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes.

Journal: American journal of respiratory and critical care medicine

Published: September 25, 2025

Differences in Arterial Oxygen Saturation Measurements Between Two Co-Oximeters From Different Manufacturers.

Differences in Arterial Oxygen Saturation Measurements Between Two Co-Oximeters From Different Manufacturers.

Journal: Respiratory care

Published: September 16, 2025

Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis.

Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis.

Journal: American journal of respiratory and critical care medicine

Published: August 11, 2025

Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT).

Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT).

Journal: American journal of respiratory and critical care medicine

Published: July 29, 2025

Longitudinal multiomic signatures of ARDS and sepsis inflammatory phenotypes identify pathways associated with mortality.

Longitudinal multiomic signatures of ARDS and sepsis inflammatory phenotypes identify pathways associated with mortality.

Journal: The Journal of clinical investigation

Published: July 09, 2025

Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality.

Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality.

Journal: medRxiv : the preprint server for health sciences

Published: June 06, 2025

Heterogeneity in association of myocardial injury and mortality in sepsis or acute respiratory distress syndrome by subphenotype: a retrospective study.

Heterogeneity in association of myocardial injury and mortality in sepsis or acute respiratory distress syndrome by subphenotype: a retrospective study.

Journal: Critical care (London, England)

Published: June 02, 2025

Delirium in hospitalized COVID-19 patients is associated with dynamic changes in peripheral immune gene expression.

Delirium in hospitalized COVID-19 patients is associated with dynamic changes in peripheral immune gene expression.

Journal: GeroScience

Published: May 16, 2025

Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality.

Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality.

Journal: JCI insight

Published: May 08, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026